Recent Quotes
My Watchlist
Indicators
Local Stocks
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Stryker Corp (NY: SYK )

389.40 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Stryker Corp

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Based on good technical signals, STRYKER CORP is potentially setting up for a breakout.
STRYKER CORP (NYSE:SYK) Reveals Intriguing Technical Aspects. Here's What You Need to Know. 
Via Chartmill
Jim Cramer Likes Cava Group, Calls This Utilities Stock 'Terrific'
On Oct. 29, Citigroup analyst Jon Tower maintained Cava Group with a Neutral and raised the price target from $115 to $140. 
Via Benzinga
Analyst Expectations For Stryker's Future
Via Benzinga
Stryker reports third quarter 2024 operating results
From Stryker Corporation
Via GlobeNewswire
Tech Stocks Rise Ahead Of Key Earnings, Gold Smashes Records, Bitcoin Nears All-Time Highs: What's Driving Markets Tuesday?
Wall Street took a breather on Tuesday, with most major indices treading water, while tech stocks saw gains as investors braced for earnings reports from mega-cap companies. 
Via Benzinga
Here's How Much $100 Invested In Stryker 10 Years Ago Would Be Worth Today
Via Benzinga
Looking Into Stryker's Recent Short Interest
Via Benzinga
The Latest Analyst Ratings For Stryker
Via Benzinga
Stryker’s Acquisition Spree: Double-Digit Growth on the Horizon
Stryker has acquired several firms over the last few months, including one related to AI. Do these purchases make the stock a buy? 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Here's How Much $100 Invested In Stryker 10 Years Ago Would Be Worth Today
Via Benzinga
Here's How Much $1000 Invested In Stryker 20 Years Ago Would Be Worth Today
Via Benzinga
How Cosmos Health’s Acquisition Of Almost 100-Year-Old Company, Adding To Capabilities Like Contract Manufacturing, Could Generate Over $10 Million In Annual Gross Profit
How Cosmos Health’s Acquisition Of Almost 100-Year-Old Company, Adding To Capabilities Like Contract Manufacturing, Could Generate Over $10 Million In Annual Gross Profit 
Via News Direct
Here's How Much You Would Have Made Owning Stryker Stock In The Last 15 Years
Via Benzinga
Deep Dive Into Stryker Stock: Analyst Perspectives (11 Ratings)
Via Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
The Benzinga Stock Whisper Index looks at five stocks seeing increased attention from readers and what could be ahead. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Stryker completes acquisition of care.ai
From Stryker Corporation
Via GlobeNewswire
Boston Scientific: Why This MedTech Giant Isn’t Slowing Down
Boston Scientific Co (NYSE: BSX) is a global medical device manufacturer that’s seeing a strong influx of investors as shares grind to new all-time highs. 
Via MarketBeat
$100 Invested In This Stock 10 Years Ago Would Be Worth $400 Today
Via Benzinga
How Is The Market Feeling About Stryker?
Via Benzinga
$100 Invested In Stryker 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Stryker Unveils New Foot & Ankle Solutions With Truss Implants: Details
Stryker Corporation announced new Foot & Ankle products from 4WEB Medical, with analysts maintaining positive ratings. 
Via Benzinga
Stryker Expands Foot & Ankle Portfolio With Specialized Offerings Designed to Enhance Surgical Precision and Outcomes
From Stryker
Via Business Wire
Medtronic Stock: Growth On Rise of the Cardiovascular Machines
Medtronic is a leading global medical device maker in the medical sector. Its innovative and critical medical device portfolio addresses chronic diseases 
Via MarketBeat
This Is Great News for Medtronic, but Is It Time to Buy the Stock?
This MedTech leader is back on track with profitable growth. 
Via The Motley Fool
Diabetes and Neuro Products Ignite Medtronic’s Q1 Earnings Rally
Medtronic's Q1 FY2025 results were driven by its diabetes products, and new offerings in development or pending FDA approval could fuel future performance. 
Via MarketBeat
Exposures Product Safety
Stryker announces definitive agreement to acquire Vertos Medical, Inc., expanding interventional pain management solutions
From Stryker Corporation
Via GlobeNewswire
Stryker to participate in the 2024 Wells Fargo Healthcare Conference
From Stryker Corporation
Via GlobeNewswire
Stryker announces definitive agreement to acquire care.ai, a leading virtual care and ambient intelligence solutions platform
From Stryker Corporation
Via GlobeNewswire
Stryker declares an $0.80 per share quarterly dividend
From Stryker Corporation
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.